Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Curebay

Explore full profile

On a mission to bridge the healthcare gap in the Indian healthcare system

Bhubaneswar Municipal Corporation, IndiaFounded 2021Biotech & Life Sciences
Valuation $50–100M Last recorded · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Curebay and the history behind them.

About Curebay

Curebay is a health-tech company established in 2020 and officially incorporated in December of that year, with operations beginning in 2021. The company was founded by Priyadarsi Mohapatra, Shobhan Mahapatra, and Sanjay Swain, who were motivated by the healthcare disparities between urban and rural India that became evident during the COVID-19 pandemic. The founders leverage extensive experience from the technology and consumer sectors. CEO Priyadarsi Mohapatra previously held leadership roles at Google, Microsoft, and SAP and co-founded a venture-capital-funded jewelry chain, Oyzterbay, which was later acquired. Co-founder Shobhan Mahapatra brings over two decades of experience from the manufacturing and IT service sectors, including a role as CIO at Birlasoft. Co-founder and CTO Sanjay Swain has a deep background in technology, with previous positions at Nielsen, TIBCO Software, and Tata Consultancy Services.

Curebay operates on a hybrid 'phygital' model designed to provide accessible and affordable healthcare to underserved populations in rural and semi-urban India. The business structure is a hub-and-spoke network, consisting of satellite e-clinics that connect patients in remote areas with healthcare providers digitally. This model addresses the significant gap in primary healthcare by reducing the need for patients to travel long distances to urban centers for quality medical attention. The company targets individuals and families in these regions who face barriers to accessing medical services due to limited infrastructure and a shortage of local specialists. Revenue is generated through the provision of these healthcare services.

The company's platform offers a comprehensive suite of services. These include scheduling doctor appointments, facilitating teleconsultations, delivering medicine, and managing diagnostic testing needs. A key feature is a concierge service that assists patients with admission to tertiary care at partner hospitals, ensuring support from admission to discharge. Through its network of over 100 e-clinics primarily in Odisha and Chhattisgarh, Curebay has provided services to more than 175,000 patients. To fuel its expansion, the company has successfully raised significant capital, including a Series A round and a $21 million Series B round in May 2025, with major investors like Elevar Equity and Bertelsmann India Investments.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Bhubaneswar Municipal Corporation, India
Employees
72
Open positions
1
Dealroom signal
57.6/100
Industry
Health
Sub-industry
Pharmaceutical, Health Platform
Sector
Biotech & Life Sciences, Healthcare Services, Electronic Health Records (EHR), Biotechnology, Telemedicine, Mobile Clinics, Biotech and Pharma
Business model
Marketplace & ecommerce
Client focus
b2b, b2c

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Aug 2026 $0 — VentureSoul Partners ↗
SERIES B✓Equity / VC May 2025 $21M $84M Elevar Equity · Bertelsmann Investments · British International Investment ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Curebay website traffic

Latest recorded traffic for Curebay is 19K monthly website visits, down 53.7% over the last three months. Curebay's team grew 0% over the past year.

Latest monthly visits19K 3-month web change-53.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Elevar Equity
  • Bertelsmann Investments
  • British International Investment

Series B and later1 investor entered at this stage

  • VentureSoul Partners

Other known investors1 additional known investor

  • Stride Ventures
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇮🇳 India98.9%
🇰🇷 South Korea0.5%
🇺🇸 United States0.5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Curebay on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Curebay’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.